Peripheral artery disease: an underdiagnosed condition in familial hypercholesterolemia? A systematic review

被引:1
|
作者
Acitelli, Elisa [1 ]
Guedon, Alexis F. [2 ]
De Liguori, Sara [1 ]
Gallo, Antonio [3 ]
Maranghi, Marianna [1 ]
机构
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[2] Sorbonne Univ, Dept Hosp Univ Inflammat Immunopathologie Biothera, APHP, Serv Med Interne, Paris, France
[3] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Nutr,INSERM ,UMR1166,Lipidol & Cardiovasc pre, 47-83 Blvd lHop, F-75013 Paris, France
关键词
LDL-cholesterol; Atherosclerosis; Dyslipidemia; Peripheral vascular disease; Hypercholesterolemia; CARDIOVASCULAR EVENTS; STATIN THERAPY; RISK-FACTORS; CHOLESTEROL; PREVALENCE; ATHEROSCLEROSIS; OUTCOMES; SCORE; METAANALYSIS; ASSOCIATION;
D O I
10.1007/s12020-024-03763-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeFamilial hypercholesterolemia (FH) is one of the most common inherited diseases characterized by elevated LDL-cholesterol levels, leading to early-onset atherosclerosis. While the association between FH and coronary and carotid artery disease is well-established, its association with peripheral artery disease (PAD) is less robust. This systematic review aims at exploring existing evidence on PAD prevalence and incidence in FH individuals.MethodsA comprehensive search was conducted on MEDLINE and Embase databases, for studies published between January 2013 and December 2023, evaluating prevalence and incidence of PAD in FH patients. Literature reviews, case reports, responses to editors and non-English language articles were excluded.ResultsThe initial research provided 53 results. After article screening, 28 articles were fully reviewed and 24 were finally included in the analysis. Among these, 19 reported PAD prevalence, while 5 PAD incidence over a mean follow-up time of 8.7 years. PAD prevalence and incidence ranged from 0.3 to 60% and from 0.5 to 4.2% respectively, probably reflecting the heterogeneity in PAD definition criteria.ConclusionThis systematic review sheds light on the limited number of studies on PAD in FH patients. Particularly, considering the potential positive effects of newly available lipid-lowering strategies on PAD outcomes, addressing this research gap is pivotal for a more comprehensive understanding of peripheral vascular manifestations in FH patients and for optimal management of this population.
引用
收藏
页码:122 / 133
页数:12
相关论文
共 50 条
  • [31] Hypertension in Patients With Peripheral Artery Disease: An Updated Literature Review
    Abraham, Andrew T.
    Mojaddedi, Sanaullah
    Loseke, Isaac H.
    Bray, Christopher
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [32] Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study
    Catapano, Federica
    Galea, Nicola
    Pambianchi, Giacomo
    D'Erasmo, Laura
    Borrazzo, Cristian
    Cundari, Giulia
    Marchitelli, Livia
    Maranghi, Marianna
    Minicocci, Ilenia
    Di Costanzo, Alessia
    Carbone, Iacopo
    Francone, Marco
    Arca, Marcello
    Catalano, Carlo
    RADIOLOGIA MEDICA, 2023, 128 (04): : 445 - 455
  • [33] Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
    Akioyamen, Leo E.
    Genest, Jacques
    Chu, Anna
    Inibhunu, Happy
    Ko, Dennis T.
    Tu, Jack V.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 15 - 30
  • [34] Physical activity and peripheral artery disease: Two prospective cohort studies and a systematic review
    Heikkila, Katriina
    Coughlin, Patrick A.
    Pentti, Jaana
    Kivimaki, Mika
    Halonen, Jaana, I
    ATHEROSCLEROSIS, 2019, 286 : 114 - 120
  • [35] Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease
    Colantonio, Lisandro D.
    Hubbard, Demetria
    Monda, Keri L.
    Mues, Katherine E.
    Huang, Lei
    Dai, Yuling
    Jackson, Elizabeth A.
    Brown, Todd M.
    Rosenson, Robert S.
    Woodward, Mark
    Muntner, Paul
    Farkouh, Michael E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 251 - 264
  • [36] Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation
    Cephus, Constance E.
    Qureshi, Athar M.
    Tejtel, S. Kristen Sexson
    Alam, Mahboob
    Moodie, Douglas S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (06) : 880 - 886
  • [37] Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
    Pereira, Carolina
    Miname, Marcio
    Makdisse, Marcia
    Kalil Filho, Roberto
    Santos, Raul D.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 103 (02) : 118 - 123
  • [38] Development of a polygenic risk score to improve detection of peripheral artery disease
    Wang, Fudi
    Ghanzouri, Ilies
    Leeper, Nicholas J.
    Tsao, Philip S.
    Ross, Elsie Gyang
    VASCULAR MEDICINE, 2022, 27 (03) : 219 - 227
  • [39] PCSK9-"missing link" in familial hypercholesterolemia. New therapeutic options in hypercholesterolemia and coronary artery disease
    Thiery, J.
    Burkhardt, R.
    HERZ, 2016, 41 (04) : 281 - 289
  • [40] Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis
    Masoura, Constantina
    Pitsavos, Christos
    Aznaouridis, Konstantinos
    Skoumas, Ioannis
    Vlachopoulos, Charalambos
    Stefanadis, Christodoulos
    ATHEROSCLEROSIS, 2011, 214 (01) : 129 - 138